Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator More Proof That Time Is Brain

被引：27
|
作者：
Alberts, Mark J. [1 ]
机构：
[1] UT Southwestern Med Ctr, Dept Neurol, Dallas, TX USA
来源：
CIRCULATION | 2017年 / 135卷 / 02期
关键词：
Editorials; alteplase; cerebrovascular disorders; stroke; tissue plasminogen activator; FUNCTIONAL OUTCOMES; THROMBOLYSIS; DELAY;
D O I：
10.1161/CIRCULATIONAHA.116.025724
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：140 / 142
页数：3
相关论文
共 50 条
  • [41] Local tissue-type plasminogen activator release in patients with ischemic stroke
    Jood, K.
    Jern, C.
    Blomstrand, C.
    Jern, S.
    Hrafnkelsdottir, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (06) : 1320 - 1323
  • [42] Tissue-type plasminogen activator should not be used in acute ischemic stroke
    Riggs, JE
    ARCHIVES OF NEUROLOGY, 1996, 53 (12) : 1306 - 1308
  • [43] Minocycline and Tissue-Type Plasminogen Activator for Stroke Assessment of Interaction Potential
    Machado, Livia S.
    Sazonova, Irina Y.
    Kozak, Anna
    Wiley, Daniel C.
    El-Remessy, Azza B.
    Ergul, Adviye
    Hess, David C.
    Waller, Jennifer L.
    Fagan, Susan C.
    STROKE, 2009, 40 (09) : 3028 - 3033
  • [44] MAKING TISSUE-TYPE PLASMINOGEN-ACTIVATOR MORE FIBRIN SPECIFIC
    PAONI, NF
    CHOW, AM
    PENA, LC
    KEYT, BA
    ZOLLER, MJ
    BENNETT, WF
    PROTEIN ENGINEERING, 1993, 6 (05): : 529 - 534
  • [45] Baseline National Institutes of Health Stroke Scale-Adjusted Time Window for Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke
    Muchada, Marian
    Rubiera, Marta
    Rodriguez-Luna, David
    Pagola, Jorge
    Flores, Alan
    Kallas, Julia
    Sanjuan, Estela
    Meler, Pilar
    Alvarez-Sabin, Jose
    Ribo, Marc
    Molina, Carlos A.
    STROKE, 2014, 45 (04) : 1059 - 1063
  • [46] Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke
    Santos, Emilie M. M.
    Dankbaar, Jan Willem
    Treurniet, Kilian M.
    Horsch, Alexander D.
    Roos, Yvo B.
    Kappelle, L. Jaap
    Niessen, Wiro J.
    Majoie, Charles B.
    Velthuis, Birgitta
    Marquering, Henk A.
    STROKE, 2016, 47 (08) : 2058 - 2065
  • [47] Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
    Leppert, Michelle H.
    Campbell, Jonathan D.
    Simpson, Jennifer R.
    Burke, James F.
    STROKE, 2015, 46 (07) : 1870 - 1876
  • [48] Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
    Saver, Jeffrey L.
    Fonarow, Gregg C.
    Smith, Eric E.
    Reeves, Mathew J.
    Grau-Sepulveda, Maria V.
    Pan, Wenqin
    Olson, DaiWai M.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Schwamm, Lee H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (23): : 2480 - 2488
  • [49] Tissue-type plasminogen activator enhanced the permeability of blood brain barrier
    Suzuki, Y
    Nagai, N
    Collen, D
    Umemura, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 82P - 82P
  • [50] Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brain
    Jeanneret, Valerie
    Ospina, Juan P.
    Diaz, Ariel
    Manrique, Luis G.
    Merino, Paola
    Gutierrez, Laura
    Torre, Enrique
    Wu, Fang
    Cheng, Lihong
    Yepes, Manuel
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2018, 38 (11): : 1896 - 1910
12345